Author: Staff

Invibio completed biocompatibility testing in China, paving the way for China Food and Drug Administration approval and local legal compliance for the company's PEEK-OPTIMA HA Enhanced spinal fusion implants.

A study published in Spine examines the readmission rates as a quality of care measure and predictor of readmission within 30 days after spine surgery.

SmartCEO Magazine named Alexander Vaccaro, MD, PhD, MBA, CEO of the Year in Philadelphia. 

With the promising potential of improving outcomes, new technologies weave into the healthcare industry. But as costs continue to rise, healthcare professionals may want to consider if the amount of improvement resulting from new technology outweighs the associated pitfalls.

Columbia's College of Physicians and Surgeons in New York offered a laboratory course on operative approaches, according to Columbia University Medical Center.

Stuart Fromm, MD, of Black Hills Orthopedic & Spine in Rapid City, S.D., developed a technique designed to enhance ACL reconstruction, according to Rapid City Journal.

The shares were sold at $40.63 per share on Nov. 6, hitting a value of $609,779.12, according Insider Trading Report.

The non-fusion spinal devices market will experience steady growth through 2025, according to a Future Market Insights report.

Lenox Hill Hospital in New York is conducting a VENUS clinical trial for Active Implants' NUsurface Meniscus Implant. Active Implants is an orthopedic implant solutions company.

Board-certified neurosurgeon Aruna Ganju, MD, serves patients at the Northwestern Center for Comprehensive Orthopaedic and Spine Care in Chicago.